WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 7001 Infant (under 12 months) mortality rate: 102
GDP / capita (US$): 1'7591 Child (under 5 years) mortality rate: 142

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 11'610  11'342  11'078  10'817  10'556  8'022  7'260  5'141 
Births 363  362  362  363  363  312  321  277 
Surviving infants 346  345  345  345  345  283  252  245 
Pop. less than 5 years 1'695  1'699  1'713  1'724  1'717  1'334  1'458  1'061 
Pop. less than 15 years 4'766  4'697  4'632  4'563  4'478  3'611  3'613  2'468 
Female 15-49 years 2'982  2'906  2'833  2'764  2'701  1'980  1'572  1'131 

Number of reported cases

(Click for retrospective incidence data for Rwanda)
Diphtheria
ChartChart
  14 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  10  17  75  31  2'095  8'970  80'402 
Mumps
ChartChart
 
Pertussis
ChartChart
  177  16'189 
Polio*
ChartChart
  24 
Rubella
ChartChart
  15  50  172  62 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  10  18  103 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Rwanda)
Vaccine year result method % card seen                                                
BCG 2013  99  DHS   94  99*  99  99*  99  99  81  57 
DTP1 2013  99  DHS   94  99*  99  99*  99*  98  93 
DTP3 2013  98  DHS   94  99*  98  99*  99*  97  90  57 
DTP4         
IPV1         
HepB_BD         
HepB3 2013  98  DHS   94  99*  98  99*  99*  97 
Hib3 2013  98  DHS   94  99*  98  99*  99*  97 
JapEnc         
MCV1          99*  97  99  99*  95  57  55 
MCV2          87  77 
PCV1          99*  99  99*  99*  98 
PCV3 2012  98  EPI   80  99*  98  99*  99*  97 
Pol3 2013  97  DHS   94  99*  98  99*  99*  93  90  58 
Rota1          99*  99  99*  99* 
RotaC          99*  98  99*  99 
RCV1          99*  97 
TT2plus 2013  34  DHS   94  99  92  78  76  62  87 
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Rwanda)
BCG
ChartChart
  99  99  99  99  99  81  92 
DTP1
ChartChart
  99  99  99  99  98  93  94 
DTP3
ChartChart
  98  98  98  98  97  90  84 
HepB3
ChartChart
  98  98  98  98  97 
HepB_BD
ChartChart
 
Hib3
ChartChart
  98  98  98  98  97 
IPV1
ChartChart
 
MCV1
ChartChart
  97  97  95  97  95  74  83 
MCV2
ChartChart
  87 
PAB
ChartChart
  90  90  85  85  85  81  85 
PCV3
ChartChart
  98  98  98  98  97 
Pol3
ChartChart
  98  98  98  98  93  90  83 
RCV1
ChartChart
  97 
RotaC
ChartChart
  98  98  98  50 
YFV
ChartChart
 

Number of districts in the country 30  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 17
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 1st contact; +2 months; Yes
IPV 14 weeks; Yes From November 2016
MR 9, 15 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10, 14 weeks; Yes
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2019  2012-2017  2012-2017  2013-2017  2013-2017  2011-2015  2008-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 30  30  30  30  30  30  30 

System performance

Total Nº districts in country number 30  30  30  30  30  30  30 
Nº districts with DTP3 coverage >=80% number 35  30  30  30  18     
% of districts with DTP3 coverage >=80% From 0 to 100% 117  100  100  100  60     
Nº districts with measles (MCV1) coverage >=95% number 18  16  19  26     
% of districts with MCV1 coverage >=95% From 0 to 100% 60  53  63  87     

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  No  Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 20  11  16  50  94  29 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.